A bunch of us from @PopVaxIndia robotics team are visiting Banglore and love to meet with the @buildpbc folks and @eddybuild
What’s the best way to reach out to them?
Cc @sohamsankaran
Folks from @PopVaxIndia, including the wonderful @RMRaghuveer and @dhruvrarora, will be at @NCBS_Bangalore tomorrow from 2-5pm to meet with students, postdocs, and researchers -- please reach out to them by replying to this post or DMing them if you'd like to meet!
My team @PopVaxIndia is looking to buy a used FPLC system for protein purification on an urgent basis for our lab in Hyderabad. In particular, we'd be happy with any of:
Cytiva (AKTA)
- AKTA Pure 25 T / M
- AKTA Pure 150 T / M
- AKTA Avant 25 T / M
- AKTA Avant 150 T / M
Bio-Rad
- NGC Scout 100
- NGC Discover 100
- NGC Quest 100 Plus
Email contact (at) popvax dot com or reply below if you are selling one or can connect us with someone who is!
Bio-Rad
- NGC Scout 100
- NGC Discover 100
- NGC Quest 100 Plus
Message me here or email [email protected] if you are selling one or can connect us with someone who is!
My team at PopVax is looking to buy a used FPLC system for protein purification on an urgent basis for our lab in Hyderabad. In particular, we'd be happy with any of:
Cytiva (AKTA)
- AKTA Pure 25 T / M
- AKTA Pure 150 T / M
- AKTA Avant 25 T / M
- AKTA Avant 150 T / M
The end of the world might start with someone asking an AI to design a deadly new virus. To combat this, @PopVaxIndia is building the Immune Engine to design & manufacture new medicines for novel pathogens in weeks, not years.
Read our essay: https://t.co/tG590PHJ9m (1/11)
As the world races to develop medicines with AI, India takes up to 2 years to approve a clinical trial. The US takes 30 days. China often needs no approval at all. In the Indian Express, @TakshashilaInst’s @anupammanur & I propose decentralizing approvals to accelerate trials. 🧵
Four years ago, I started @PopVaxIndia with no real knowledge of biology and <$50k in personal funding, convinced that the combination of generative AI for design & RNA for delivery would unlock a new class of vaccines & therapeutics against diseases resistant to legacy methods.
Capacity building workshop for scientific research in India:
Are you a MSc student?
PhD scholar?
Academic scientist?
Anyone can join!
A workshop which will assess you in every aspect, to improve your capacity to understand, do and communicate science.
https://t.co/l0FNAYRAJC
Cover drop! 🥳
'The Real Deal: Lessons, Learnings, and Laughter for Girl Scientists'
Releases in January 2026. Watch this space for promotion offers, insider peeks, and more!
More here: https://t.co/76EKKCTaTu
A workshop for capacity building of PhD scholars in India
Further details- https://t.co/W0BPYyJ7Mv
Form-https://t.co/4ZYn6SVEAW
I am available at karthicscicomm [at] gmail [dot] com if you need to ask any questions.
I am neither a academic scientist/science faculty nor a PhD scholar.
But, I have gained a few skills and capacities which are important for both the people.
The process of my self development focusing towards pursuing and communicating science was kindled by the...
Great to see Vox highlighting @sohamsankaran & @PopVaxIndia’s mission of building full-stack RNA medicines engine end-to-end, creating novel vaccines & immunotherapies that can save 1M lives a year.
A self-reliant India is the medicine for countless sorrows!
@sohamsankaran left a Cornell PhD during the pandemic to tackle vaccine inequality.
In 2021, he founded @PopVaxIndia to build broad mRNA vaccines that protect against entire virus families. His AI-driven approach is getting noticed. #FuturePerfect25 https://t.co/N2zhtu8kcx
An online workshop on researching, writing and publishing in agriculture and related fields. For scientists and science faculty in India. https://t.co/0sgGK9pSfv